Qiuheng Jin

Dr. Qiuheng Jin

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2016 in Genes & Development
Verified
Journal Article
Open access
PDF file
FMFansen Meng
Fansen Meng
RZRuyuan Zhou
Ruyuan Zhou
SWShiying Wu
Shiying Wu
QZQian Zhang
Qian Zhang
QJQiuheng Jin
Qiuheng Jin
Pinglong XuPinglong Xu
Pinglong Xu
Cytosolic RNA/DNA sensing elicits primary defense against viral pathogens. Interferon regulatory factor 3 (IRF3), a key signal mediator/transcriptional factor of the antiviral-sensing pathway, is indispensible for interferon production and antiviral defense. However, how the status of IRF3 activation is controlled remains elusive. Through a functional screen of the human kinome, we found that mammalian sterile 20-like kinase 1 (Mst1), but not Mst2, profoundly inhibited cytosolic nucleic acid sensing. Mst1 associated with IRF3 and directly phosphorylated IRF3 at Thr75 and Thr253. This Mst1-mediated phosphorylation abolished activated IRF3 homodimerization, its occupancy on chromatin, and subsequent IRF3-mediated transcriptional responses. In addition, Mst1 also impeded virus-induced activation of TANK-binding kinase 1 (TBK1), further attenuating IRF3 activation. As a result, Mst1 depletion or ablation enabled an enhanced antiviral response and defense in cells and mice. Therefore, the identification of Mst1 as a novel physiological negative regulator of IRF3 activation provides mechanistic insights into innate antiviral defense and potential antiviral prevention strategies.

3 April 2020 in Cell Research
Verified
Journal Article
Closed access
PDF file
QJQiuheng Jin
Qiuheng Jin
BZBo Zhang
Bo Zhang
XZXiang Zheng
Xiang Zheng
NLNingning Li
Ningning Li
LXLingyi Xu
Lingyi Xu
SYSheng Ye
Sheng Ye

15 May 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
BZBo Zhang
Bo Zhang
QJQiuheng Jin
Qiuheng Jin
LXLizhen Xu
Lizhen Xu
NLNingning Li
Ningning Li
YMYing Meng
Ying Meng
SYSheng Ye
Sheng Ye
Proton-linked monocarboxylate transporters (MCTs) must transport monocarboxylate efficiently to facilitate monocarboxylate efflux in glycolytically active cells, and transport monocarboxylate slowly or even shut down to maintain a physiological monocarboxylate concentration in glycolytically inactive cells. To discover how MCTs solve this fundamental aspect of intracellular monocarboxylate homeostasis in the context of multicellular organisms, we analyzed pyruvate transport activity of human monocarboxylate transporter 2 (MCT2). Here we show that MCT2 transport activity exhibits steep dependence on substrate concentration. This property allows MCTs to turn on almost like a switch, which is physiologically crucial to the operation of MCTs in the cellular context. We further determined the cryo-electron microscopy structure of the human MCT2, demonstrating that the concentration sensitivity of MCT2 arises from the strong inter-subunit cooperativity of the MCT2 dimer during transport. These data establish definitively a clear example of evolutionary optimization of protein function.

1 June 2017 in Cell Host & Microbe
Verified
Journal Article
Closed access
SLShengduo Liu
Shengduo Liu
SCShasha Chen
Shasha Chen
XLXinran Li
Xinran Li
SWShiying Wu
Shiying Wu
QZQian Zhang
Qian Zhang
Pinglong XuPinglong Xu
Pinglong Xu

1 July 2024 in Chemosensors
Verified
Journal Article
Open access
PDF file
FCfeiran cheng
feiran cheng
JLJi Li
Ji Li
CHChaoying Hu
Chaoying Hu
YBYu Bai
Yu Bai
JLJifeng Liu
Jifeng Liu
MXMiao Xu
Miao Xu
Circular RNA (circRNA) vaccines have attracted increasing attention due to their stable closed-loop structures and persistent protein expression ability. During the synthesis process, nicked circRNAs with similar molecular weights to those of circRNAs are generated. Analytical techniques based on differences in molecular weight, such as capillary electrophoresis, struggle to distinguish between circRNAs and nicked circRNAs. The characteristic degradation products of circRNAs and their biological activities remain unclear. Therefore, developing methods to identify target circRNAs and non-target components and investigating degradation patterns will be beneficial to gaining an in-depth understanding of the properties and quality control of circRNAs vaccines. The reversed-phase HPLC (RP-HPLC) method was established for identification of target circRNAs, product-related substances, and impurities. Subsequently, we investigated the degradation patterns of circRNAs under thermal acceleration conditions and performed biological analysis of degradation products and linear precursors. Here, RP-HPLC method effectively identified circRNAs and nicked circRNAs. With thermal acceleration, circRNAs exhibited a “circular→nicked circRNAs→degradation products” degradation pattern. Biological analysis revealed that the immunogenicity of degradation products significantly decreased, whereas linear precursors did not possess immunogenicity. Thus, our established RP-HPLC method can be used for purity analysis of circRNA vaccines, which contributes to the quality control of circRNA vaccines and promoting the development of circRNA technology.

5 July 2019 in Analytical Chemistry
Verified
Journal Article
Closed access
JWJian-Wei Wang
Jian-Wei Wang
JGJie Gao
Jie Gao
HWHui-Feng Wang
Hui-Feng Wang
QJQiuheng Jin
Qiuheng Jin
BRBing Rao
Bing Rao
QFQun Fang
Qun Fang